U#3888_MH_ResearchReport (S)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Research Report 2017<br />
Clinical Haematology<br />
Monash Haematology is a dynamic, multidisciplinary clinical and academic team.<br />
Working across the spectrum of haematologic conditions, and with collaborators in<br />
many different disciplines nationally and internationally, we are focused on generating<br />
important new evidence to inform practice, and integrating this into high-quality,<br />
patient-centered care.<br />
2017 at a glance<br />
12,538<br />
outpatient attendances<br />
68% growth over 5 years<br />
9,594<br />
Inpatient admissions<br />
45% growth over 5 years<br />
4,356<br />
Inpatient WIES<br />
50<br />
Active Clinical Trials<br />
36<br />
abstracts<br />
at<br />
international<br />
meetings<br />
40<br />
Patients on active follow up<br />
53<br />
Peer reviewed Publications<br />
41<br />
Invitations to present nationally<br />
and internationally<br />
Monash Haematology provides<br />
haematology care to a population of<br />
approximately 1.3 million, making it<br />
one of the largest services in Australia.<br />
Clinical and diagnostic services are<br />
provided at all five major sites of<br />
Monash Health with the unit having<br />
primary responsibility for 30 inpatients<br />
and a consultative service for over 100<br />
inpatients per week.<br />
Key leadership areas in clinical care<br />
and research include lymphoid<br />
cancer, chronic myeloid disorders,<br />
venous thromboembolic disease,<br />
haemoglobinopathy, transfusion<br />
medicine, molecular pathology and<br />
genomics. There are dedicated<br />
outpatient services for lymphoid<br />
cancer (including myeloma), disorders<br />
of haemostasis and thrombosis,<br />
haemoglobinopathy, and myeloid<br />
diseases.<br />
The unit has a large clinical trials<br />
program and is currently involved in<br />
over 50 studies, particularly in areas<br />
of lymphoid cancer and thrombosis.<br />
Nearly half of the hospitals clinical<br />
research output is provided by<br />
haematology. In addition there is an<br />
established basic science research<br />
program with a lead clinician and<br />
dedicated scientist. The service was<br />
involved in the establishment of the<br />
Australasian Lymphoma and related<br />
disease registry and is the lead site<br />
for the Melbourne Genomics Health<br />
Alliance High risk Lymphoma flagship.<br />
The service is one of the major<br />
providers of training in haematology,<br />
currently employing seven registrars<br />
and four research fellows. It has a large<br />
academic output (53 publications in<br />
2017, many as first or senior author)<br />
It is an active member of a number of<br />
research organisations including the<br />
Monash Health Translation Precinct<br />
(<strong>MH</strong>TP), the Centre for Cancer<br />
Research (CCR) at the Hudson Institute<br />
of Medical Research, the Australasian<br />
Leukaemia and Lymphoma Group, the<br />
Children’s Oncology Group. In addition<br />
there is an emerging basic science<br />
research program embedded within<br />
the state-of-the-art Monash Health<br />
Translational facility.<br />
37